Table 3. Post-implant adverse events.

Event	LVEDD <65 mm, n=126	LVEDD >65 mm, n=165	P value
Infection	39 (46.4%)	53 (44.5%)	0.79
Bleeding	31 (36.9%)	43 (36.1%)	0.91
Reoperation (all-cause)	21 (25.0%)	34 (28.6%)	0.57
Reoperation for tamponade	16 (19.0%)	13 (10.9%)	0.10
Renal failure	17 (20.2%)	16 (13.4%)	0.20
Hepatic dysfunction	2 (2.4%)	4 (3.4%)	0.68
Stroke	15 (17.9%)	15 (12.6%)	0.30
Right ventricular failure	11 (13.1%)	13 (10.9%)	0.64
RVAD	2 (2.4%)	6 (5.0%)	0.34
Device dysfunction	11 (13.1%)	19 (16.0%)	0.57
Device thrombosis	3 (3.6%)	4 (3.4%)	0.94
Hemolysis	7 (8.3%)	6 (5.0%)	0.35
30-day mortality	7 (4.2%)	3 (2.8%)	0.48
1-year mortality	23 (18.3%)	26 (15.8%)	0.57
Overall mortality	51 (40.5%)	56 (33.9%)	0.25
Device explanted	6 (7.1%)	13 (10.9%)	0.35

LVEDD, left ventricular diastolic diameter.